BioSpace News Archive

BioCapital

CepTor Corporation Reports Two Issues Remain To Move Myodur IND Forward

October 9, 2006
·
1 min read
Drug Development

Actelion Ltd.: Detailed Analysis Of CONSCIOUS-1 Presented At CNS

October 9, 2006
·
1 min read
Deals

Pfizer Inc. Expands Commitment To Fight Infectious Diseases With Agreement To Acquire Vaccine Company PowderMed Ltd

October 9, 2006
·
5 min read
FDA

FDA Approves Merck & Co., Inc.'s ZOLINZA(TM) For The Treatment Of Cutaneous Manifestations In Patients With Cutaneous T-Cell Lymphoma Who Have Tried And Failed Other Therapies

October 9, 2006
·
9 min read
Business

Monsanto Company Sets Webcast And Analyst/Media Call For 2006 Fourth-Quarter And Fiscal-Year Financial Results

October 9, 2006
·
1 min read
Business

Covance Inc. Invites You To Join The Webcast Of Its Third Quarter 2006 Financial Results Conference Call

October 9, 2006
·
1 min read
Drug Development

FDA Initiates Phase III Trial Of Lofexidine For Treatment Of Opiate Withdrawal Symptoms

October 9, 2006
·
1 min read
Drug Development

Bristol-Myers Squibb Company, Merck & Co., Inc. And Gilead Sciences (Foster City, CA) Submit Marketing Authorisation Application For ATRIPLA(TM) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) To European Medicines Agency

October 9, 2006
·
21 min read
Pharm Country

First U.S. Presentation Of CORTOSS(R) IDE Pivotal Clinical Preliminary Data To Be Presented In A Poster At The Congress Of Neurological Surgeons In Chicago

October 9, 2006
·
1 min read
Policy

FDA Issues Approvable Letter For New River Pharmaceuticals Inc. And Shire Pharmaceuticals’s NRP104 For The Treatment Of ADHD

October 9, 2006
·
10 min read